Feb 08, 2016 at 13:14 | Source: CNBC-TV18
Dipan Mehta, Member at BSE & NSE is of the view that there are opportunities in pharma stocks and feels that Alembic Pharma looks interesting.
Feb 08, 2016 at 13:09 | Source: CNBC-TV18
Dipan Mehta, Member at BSE & NSE has a negative view on PSU banks while one may find opportunities in private banking space.
Feb 08, 2016 at 12:51 | Source: CNBC-TV18
The company is working to expand its installation and marketing base, says Rahul Khettry, CFO of the company. Control Prints current market share is 18-19 percent in India.
Feb 08, 2016 at 12:33 | Source: CNBC-TV18
PP Gupta, MD of Techno Electric & Engineering expects good market from transmission over next three to four years.
Feb 08, 2016 at 12:26 | Source: CNBC-TV18
Exercise of rationalisation of costs is a continuous process, said Rajesh Kumar Mohta, CFO, Speciality Restaurants so that good money does not get turned into bad money.
Feb 08, 2016 at 12:20 | Source: CNBC-TV18
Speaking to CNBC-TV18, Dipan Mehta, member BSE and NSE says midcap IT and pharmaceutical names are a better investment idea than largecaps.
Feb 08, 2016 at 12:19 | Source: CNBC-TV18
CA Rudramurthy BV of Vachana Investments recommends selling Bosch and Jubilant Foodworks and advises buying Bata India.
Feb 08, 2016 at 12:04 | Source: CNBC-TV18
Won't be influenced or swayed by comments on spectrum pricing, Ravi Shankar Prasad said in an interview with CNBC-TV18.
Feb 08, 2016 at 12:02 | Source: CNBC-TV18
Watch the interview of T Gnanasekar of CommTrendz Research & Fund Management with Anuj Singhal and Ekta Batra on CNBC-TV18. He spoke about the current trend in commodities markets.
Feb 08, 2016 at 12:00 | Source: CNBC-TV18
The government has kept certain products out of the minimum import price net, such as scrap, hot briquetted iron, high grade pipes used in the petroleum industry as well as imports allowed under the advance authorisations scheme